Literature DB >> 19018152

Comparison of the efficacies of antibiotic-impregnated and silver-impregnated ventricular catheters on the prevention of infections. An in vitro laboratory study.

Halil Ibrahim Secer1, Cahit Kural, Metin Kaplan, Abdullah Kilic, Bulent Duz, Engin Gonul, Yusuf Izci.   

Abstract

BACKGROUND AND
OBJECTIVE: Infection of the cerebrospinal fluid is a life-threatening condition which is usually treated with systemic antibiotics and continued ventricular drainage in children. The aim of this study was to analyze the antimicrobial activities of two antimicrobial-agent-impregnated ventricular catheters and to compare their efficacies on the bacterial cultures.
METHODS: Antibiotic-impregnated (clindamycin and rifampicin), silver-impregnated, and standard ventricular catheters were used in this study. The experiment was performed in 2 steps. In the first step, small pieces of the catheters were cut and incubated. Then, they were washed and placed in agar medium. Finally, the number of colonies was counted. In the second step, the pieces of catheters were placed on agar plates containing Staphylococcus aureus,Staphylococcus epidermidis, and Pseudomonas aeruginosa. The plates were incubated, and then, the inhibition zone for each catheter was measured.
RESULTS: An inhibition zone was observed only in the plates for antibiotic-impregnated catheters. In the other plates, no inhibition zone was detected. The number of colonies was lowest in the plate with the silver-impregnated catheter, followed by the antibiotic-impregnated and standard catheters.
CONCLUSION: The antibiotic-impregnated catheter seems more effective for antimicrobial treatment. Although no inhibition zone was found in the plates for silver-impregnated catheters, these catheters allow the lowest bacterial colonization in agar. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018152     DOI: 10.1159/000172966

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  7 in total

Review 1.  Strategies to decrease the risk of ventricular catheter infections: a review of the evidence.

Authors:  Maya A Babu; Robin Patel; W Richard Marsh; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

2.  The efficacy of silver-embedded polypropylene-grafted polyethylene glycol-coated ventricular catheters on prevention of shunt catheter infection in rats.

Authors:  Derya Burcu Hazer; Melike Mut; Nazmiye Dinçer; Zeynep Saribas; Baki Hazer; Tunçalp Ozgen
Journal:  Childs Nerv Syst       Date:  2012-02-29       Impact factor: 1.475

3.  In vitro efficacy of antimicrobial-treated drainage catheters in preventing bacterial colonization in biological fluids.

Authors:  Mohammad D Mansouri; Leah Awan; Rabih O Darouiche
Journal:  Infect Control Hosp Epidemiol       Date:  2011-07       Impact factor: 3.254

4.  Bactericidal effects of silver plus titanium dioxide-coated endotracheal tubes on Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  Keiko M Tarquinio; Nikhil K Kothurkar; Dharendra Y Goswami; Ronald C Sanders; Arno L Zaritsky; Ann Marie LeVine
Journal:  Int J Nanomedicine       Date:  2010-04-07

5.  Management of ventriculo-peritoneal shunts in the paediatric population.

Authors:  David Low; James M Drake; Wan Tew Seow; Wai Hoe Ng
Journal:  Asian J Neurosurg       Date:  2010-01

6.  Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT.

Authors:  Conor L Mallucci; Michael D Jenkinson; Elizabeth J Conroy; John C Hartley; Michaela Brown; Tracy Moitt; Joanne Dalton; Tom Kearns; Michael J Griffiths; Giovanna Culeddu; Tom Solomon; Dyfrig Hughes; Carrol Gamble
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

7.  Dynamic Adaptive Response of Pseudomonas aeruginosa to Clindamycin/Rifampicin-Impregnated Catheters.

Authors:  Kidon Sung; Jungwhan Chon; Ohgew Kweon; Seongwon Nho; Seongjae Kim; Miseon Park; Angel Paredes; Jin-Hee Lim; Saeed A Khan; Kenneth Scott Phillips; Carl E Cerniglia
Journal:  Antibiotics (Basel)       Date:  2021-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.